Ladenburg Thalmann Financial Services’s Atara Biotherapeutics ATRA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$3K	Buy	6 +4	+200%	+$1.38K	﹤0.01%	4937
2019 Q3	$1K	Hold	2	–	–	﹤0.01%	5074
2019 Q2	$1K	Sell	2 -4	-67%	-$2.82K	﹤0.01%	5068
2019 Q1	$6K	Buy	6 +4	+200%	+$3.72K	﹤0.01%	4571
2018 Q4	$1K	Hold	2	–	–	﹤0.01%	4999
2018 Q3	$2K	Hold	2	–	–	﹤0.01%	4845
2018 Q2	$2K	Hold	2	–	–	﹤0.01%	4837
2018 Q1	$2K	Hold	2	–	–	﹤0.01%	4837
2017 Q4	$1K	Hold	2	–	–	﹤0.01%	4874
2017 Q3	$1K	Hold	2	–	–	﹤0.01%	4765
2017 Q2	$1K	Hold	2	–	–	﹤0.01%	4700
2017 Q1	$1K	Hold	2	–	–	﹤0.01%	4677
2016 Q4	$1K	Buy	2 +1	+100%	+$423	﹤0.01%	4622
2016 Q3	$0	Hold	1	–	–	﹤0.01%	4768
2016 Q2	$0	Hold	1	–	–	﹤0.01%	4738
2016 Q1	$0	Sell	1 -1	-50%	-$450	﹤0.01%	4680
2015 Q4	$1K	Buy	2 +1	+100%	+$756	﹤0.01%	4472
2015 Q3	$1K	Buy	+1	New	+$1.22K	﹤0.01%	4379

Other funds holding ATRA

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ATRA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Atara Biotherapeutics (ATRA) stake by 200% in Q4 2019, buying an estimated $1.38K and bringing the position to 6 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4937.

Ladenburg Thalmann Financial Services first reported a position in ATRA in Q3 2015 and has held it in 18 quarters since. The position peaked at $6K in Q1 2019. 117 funds tracked by Wall St. Rank hold ATRA as of Q4 2019.

Ladenburg Thalmann Financial Services held 6 shares of Atara Biotherapeutics worth $3K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 4 Atara Biotherapeutics shares in Q4 2019, an estimated $1.38K.
Atara Biotherapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4937 holding.
Ladenburg Thalmann Financial Services first reported a position in Atara Biotherapeutics in Q3 2015 and has held it in 18 quarters since.
Ladenburg Thalmann Financial Services's Atara Biotherapeutics position peaked at $6K in Q1 2019.
117 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.